These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38543159)

  • 1. Evaluating Prognosis of Gastrointestinal Metastatic Neuroendocrine Tumors: Constructing a Novel Prognostic Nomogram Based on NETPET Score and Metabolic Parameters from PET/CT Imaging.
    Liu Y; Cui R; Wang Z; Lin Q; Tang W; Zhang B; Li G; Wang Z
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms based on SUVmax of
    Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
    Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor.
    Sharma P; Naswa N; Kc SS; Alvarado LA; Dwivedi AK; Yadav Y; Kumar R; Ammini AC; Bal C
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2194-202. PubMed ID: 25030618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of
    Song Y; Tian Y; Lu X; Chen G; Lv X
    Med Phys; 2024 Jul; 51(7):4907-4921. PubMed ID: 38252704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual [
    Chan DL; Hayes AR; Karfis I; Conner A; Furtado O'Mahony L; Mileva M; Bernard E; Roach P; Marin G; Pavlakis N; Schembri G; Gnanasegaran G; Marin C; Vanderlinden B; Navalkissoor S; Caplin ME; Flamen P; Toumpanakis C; Bailey DL
    Br J Cancer; 2023 Feb; 128(4):549-555. PubMed ID: 36434154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential Prognostic Value of Dual-Imaging PET Parameters Based on
    Hou J; Long T; Yang Y; Chen D; Hu S
    Mol Imaging; 2022; 2022():6511179. PubMed ID: 35368455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer.
    Jia T; Lv Q; Cai X; Ge S; Sang S; Zhang B; Yu C; Deng S
    Front Oncol; 2023; 13():1210125. PubMed ID: 37576897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of
    Luo Y; Huang Z; Gao Z; Wang B; Zhang Y; Bai Y; Wu Q; Wang M
    Korean J Radiol; 2024 Feb; 25(2):189-198. PubMed ID: 38288898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.
    Hindié E
    Theranostics; 2017; 7(5):1159-1163. PubMed ID: 28435455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [
    Dongxiang W; Liting L; Yujing L; Meijuan L; Shanshan G; Longbin X; Yanzhou C; Meiling C; Kang N; Haiqiang M; Linquan T; Qiuyan C
    Eur Radiol; 2023 Apr; 33(4):2840-2849. PubMed ID: 36422647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of
    Adnan A; Basu S
    J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of an
    Dong X; Wang R; Ying X; Xu J; Yan J; Xu P; Peng Y; Chen B
    Hematology; 2024 Dec; 29(1):2329029. PubMed ID: 38488443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker.
    Chan DL; Ulaner GA; Pattison D; Wyld D; Ladwa R; Kirchner J; Li BT; Lai WV; Pavlakis N; Roach PJ; Bailey DL
    J Nucl Med; 2021 Sep; 62(9):1278-1284. PubMed ID: 33579809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
    Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and validation of a nomogram with intratumoral heterogeneity derived from
    Gu B; Zhang J; Ma G; Song S; Shi L; Zhang Y; Yang Z
    BMC Cancer; 2020 Jan; 20(1):37. PubMed ID: 31941465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a [
    Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
    Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel analytical approach for outcome prediction in newly diagnosed NSCLC based on [
    Zhang L; Xu C; Zhang X; Wang J; Jiang H; Chen J; Zhang H
    Eur Radiol; 2023 Mar; 33(3):1757-1768. PubMed ID: 36222865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.